Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of ANAVEX2-73 in Patients With Rett Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03758924
Recruitment Status : Recruiting
First Posted : November 29, 2018
Last Update Posted : March 28, 2019
Sponsor:
Collaborator:
International Rett Syndrome Foundation Rettsyndrome.org
Information provided by (Responsible Party):
Anavex Life Sciences Corp.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : November 1, 2019
  Estimated Study Completion Date : December 30, 2019